Prot# SAT1-05-02: Phase I Study of the Oral Platinum Agent Satraplatin (JM-216) in Combination with Capecitabine in the Treatment of Patients with Advanced Solid Malignancies

Project: Research project

Project Details

StatusFinished
Effective start/end date4/20/064/1/12

Funding

  • GPC Biotech Inc. (SAT1-05-02)